Found: 11
Select item for more details and to access through your institution.
Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1534, doi. 10.1111/apt.16848
- By:
- Publication type:
- Article
Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE Program.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 4, p. 604, doi. 10.1159/000528788
- By:
- Publication type:
- Article
Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program.
- Published in:
- Patient, 2023, v. 16, n. 2, p. 95, doi. 10.1007/s40271-022-00603-w
- By:
- Publication type:
- Article
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 2, p. 240, doi. 10.1002/acr.24966
- By:
- Publication type:
- Article
Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost-Utility Analysis of a Multidisciplinary Strategy to Manage Osteoarthritis of the Knee: Economic Evaluation of a Cluster Randomized Controlled Trial Study.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 6, p. 810, doi. 10.1002/acr.22232
- By:
- Publication type:
- Article
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 2, p. 357, doi. 10.1007/s40744-022-00507-z
- By:
- Publication type:
- Article
Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1283, doi. 10.1093/ecco-jcc/jjae031
- By:
- Publication type:
- Article
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 8, p. 1218, doi. 10.1002/art.42846
- By:
- Publication type:
- Article
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231189122
- By:
- Publication type:
- Article
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231189122
- By:
- Publication type:
- Article